Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 18.00
+0.95 (5.57%)
Sep 2, 2026, 5:29 PM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 1.56 billion as of September 2, 2026. Its market cap has decreased by -51.86% in one year.
Market Cap
1.56B
Enterprise Value
1.26B
Revenue
-5.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.00
ChartMarket Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 1.56B, a decrease of -62.00%. That is a compound annual growth rate of -35.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.56B | -46.20% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 4.53B |
| Egetis Therapeutics AB | 3.72B |
| Vicore Pharma Holding AB | 2.98B |
| Saniona AB | 1.60B |
| BioInvent International AB | 1.55B |
| Genovis AB (publ.) | 1.51B |
| Medivir AB | 1.22B |
| SynAct Pharma AB | 1.12B |